Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n- propylamino)tetralin at human (h)D3, hD2 and h serotonin(1A) receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1241-1249

  Lejeune, F ^a   Newman Tancredi, A ^a   Audinot, V ^a   Millan, M J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HALOPERIDOL; TERTATOLOL; TETRALIN DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; DOPAMINE BLOOD LEVEL; DOSE RESPONSE; ELECTROSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; SEROTONIN BLOOD LEVEL; SEROTONINERGIC NERVE CELL; STEREOSPECIFICITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HUMANS; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TETRAHYDRONAPHTHALENES;

EID: 0030898020     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. AGHAJANIAN, G. K., WANG, R. Y. AND BARABAN, J.: Serotonergic and non-serotonergic neurons of the dorsal raphe: Reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res. 153: 169-175, 1978.
2. AHLENIUS, S., HILLEGAART, V. AND WIJKSTRÖM, A.: Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. J. Pharm. Pharmacol. 42: 285-288, 1990.
3. ARBORELIUS, L., NOMIKOS, G. G., HACKSELL, U. AND SVENSSON, T. H.: (R)-8-OH-DPAT preferentially increases dopamine release in the rat medial prefrontal cortex. Acta Physiol. Scand. 148: 465-466, 1993a.
4. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg Arch. Pharmacol. 347: 353-362, 1993b.
5. 3 subtypes. Brain Res. 649: 95-110, 1994.
6. 3 receptors. Eur. J. Pharmacol. 239: 269-270, 1993.
7. BECKSTEAD, R. M., DOMESICK, V. B. AND NAUTA, W. J. H.: Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res., 175: 191-217, 1979.
8. BENLOUCIF, S., KEEGAN, M. J. AND GALLOWAY, M. P.: Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmac. Exp. Ther. 265: 372-377, 1993.
9. 2. Neuropsychopharmacology 10: 237S, 1994.
10. 1A receptors in the brain. J. Med. Chem. 32: 779-783, 1989.
11. BLIER, P., STEINBERG, S., CHAPUT, Y. AND DE MONTIGNY, C.: Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: A single-cell study in the rat dorsal raphe nucleus. Can. J. Physiol. Pharmacol. 67: 98-10, 1988.
12. 125I]iodosulpride. Neuroscience 20: 117-155, 1987.
13. BROEKKAMP, C. L. E., LEVSEN, D., PEETERS, B. W. M. M. AND PINDER, R. M.: Prospect of improved antidepressants. J. Med. Chem. 38: 4615-4633, 1995.
14. 3 dopamine receptors. Neuropsychopharmacology 12: 335-345, 1995.
15. CHEN, N.-H. AND REITH, E. A.: Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 64: 1585-1597, 1995.
16. 2 dopamine receptors. Mol. Pharmacol. 45: 51-60, 1993.
17. 1A receptors that are negatively coupled to adenylate cyclase. Molecular Pharmacol. 39: 780-787. 1991.
18. 3 receptor ligand. Eur. J. Pharmacol. 249: R9-R10, 1993.
19. DE SIMONI, M. G., DAL Toso, G., FODRITTO, F., SOKOLA, A. AND ALGERI, S.: Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences. Brain Res. 411: 81-88, 1987.
20. DEUTCH, A. Y., MOGHADDAM, B., INNIS, R. B., KRYSTAL, J. H., AGHAJANIAN, G. K., BUNNEY, B. S. AND CHARNEY, D. S.: Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophrenia Res. 4: 121-156, 1991.
21. DRAY. A., DAVIES, J., OAKLEY, N. R., TONGROACH, P. AND VELUCCI, S.: The dorsal and medial projections to the substantia nigra in the rat: Electrophysiological, biochemical and behavioral observations. Brain Res. 151: 431-442, 1978.
22. 2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J. Neurochem. 61: 772-775, 1993.
23. FERRÉ, S., CORTÈS, R. AKD ARTIGAS, F.: Dopaminergic regulation of the serotonergic raphe-striatal pathway: Microdialysis studies in freely moving rats. J. Neurosci. 14: 4839-4846, 1994.
24. 1A receptor agonists. Drug Dev. Res. 34: 66-85, 1995.
25. GEFFARD, M., TUFFET, S., MONS, N. AND CHAGNAUD, J.-L.: Simultaneous detection of indolamines and dopamine in rat dorsal raphe nuclei using specific antibodies. Histochemistry 88: 61-64, 1987.
26. GERVAIS, J. AND ROUILLARD, C.: Electrophysiological responses of mesencephalic dopamine neurons to dorsal raphe stimulation in 5-HT-depleted rats. Soc. Neurosci. Abstr. 19: 1372, 1993.
27. GIAMBALO, G. T. AND SNODGRASS, S. R.: Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: Comparison of injection sites. Brain Res. 152: 555-566, 1978.
28. 1A receptor agonists and antagonists: A comparison to adrenergic and dopaminergic neurons in rats. J. Pharmacol. Exp. Ther. 273: 1032-1046, 1995a.
29. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol. Exp. Ther. 275: 899-913, 1995b.
30. 1A receptor ligand, S 15535. Eur. J. Neurosci. 8: 16, 1995c.
31. 3 antagonist, (+)-S 14297. J. Neurochem. 66: 2209-2212, 1996.
32. 3 receptors. Eur. J. Pharmacol. 272: R1-R3, 1995
33. 3H]7-hydroxy-N, N-di-n-propyl-2-aminotetralin. Brain Res. 648: 222-228, 1994.
34. HERVÉ, D., PICKEL, V. M., JOH, T. H. AND BEAUDET, A.: Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res. 435: 71-83, 1987.
35. 1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol. 287: 179-184, 1995.
36. 1A receptors in the rat brain, Naunyn-Schmiedeberg Arch. Pharmacol. 347: 453-463, 1993.
37. KALÉN, P., SKAGERBERG, G. AND LINDVALL, O.: Projections from the ventral tegmental area and mesencephalic raphe to the dorsal raphe nucleus of the rat. Exp. Brain Res. 73: 69-77, 1988.
38. KELLAND, M. D., FREEMAN, A. S. AND CHIODO, L. A.: Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J. Pharmac. Exp. Ther. 253: 803-811, 1990.
39. LEE, E. H. Y. AND GEYER, M. A.: Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons. Pharmac. Biochem. Behav. 21: 301-311, 1984.
40. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurons in vivo. Eur. J. Pharmacol. 275: R7-R9, 1995.
41. 1A receptors. Eur. J. Pharmacol. 260: 79-83, 1994.
42. 1A autoreceptors enhances dopamine (DA) and noradrenaline (NAD) release in rat FCx: Influence of S 15535, WAY 100,635 and 8-OH-DPAT. Eur. J. Neurosci. 6: S4-121, 1996.
43. 1A receptors in the dorsal raphe nucleus. Eur. J. Pharmacol. 149: 9-15, 1988.
44. 3 receptors. Mol. Pharmacol. 46: 299-312, 1994.
45. 1A agonists. Mol. Pharmacol. 37: 231-237, 1990.
46. MELTZER, H. Y.: The importance of serotonin-dopamine interactions in the action of clozapine. Br. J. Psychiatry 160: 22-29, 1992.
47. 1A antagonists. J. Pharmacol. Exp. Ther. 268: 337-351, 1994.
48. 3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: I. Activation of postsynaptic D3 receptors mediates hypothermia while blockade of D2 receptors elicits prolactin secretion and catalepsy. J. Pharmac. Exp. Ther. 275: 885-898, 1995.
49. 1A receptors: I. Interaction with cloned human (h)S-HT1A, dopamine hD2/D3 and hα2A-adrenergic receptors in relation to modulation of cortical monoamine release and potential antidepressant properties. Submitted, 1996.
50. 1A receptors: Respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem. Int. 19: 453-465, 1991.
51. 3H](+)S 14297: A novel, selective radioligand at cloned human dopamine D3 receptors. Neuropharmacology 34: 1693-1696, 1995.
52. 1A receptors. Neuropharmacology 35: 119-121, 1996.
53. 1A receptors in Chinese hamster ovary cells. Biochem. J. 285: 933-938, 1992.
54. PALACIOS, J. M. AND PAZOS, A.: Visualization of dopamine receptors: A progress review. In Dopamine Receptors, ed. by I. Creese and C. Fraser, pp. 175-197. Alan R. Liss Inc., New York, 1987.
55. PATEL, J., TROUT, S. J., PALIJ, P., WHELPTON, R. AND KRUK, Z. L.: Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br. J. Pharmacol. 115: 421-426, 1995.
56. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, 1986.
57. PAZOS, A. AND PALACIOS, J. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Serotonin-1 receptors. Brain Res. 346: 205-230, 1985.
58. PRISCO, S., PAGANNONE, S. AND ESPOSITO, E.: Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo. J. Pharmac. Exp. Ther. 271: 83-90, 1994.
59. 3 receptor antagonist, (+)-S 14297. Eur. J. Pharmacol. 265: 175-177, 1994.
60. 1 receptor. Eur. J. Pharmacol. 157: 173-181, 1988.
61. SMITH, C. F. C. AND CUTTS S. D.: Dopamine agonist activity of 8-OH-DPAT. Br. J. Pharmacol. 98: 755P, 1989.
62. SOKOLOFF, P. AND SCHWARTZ, J.-C.: Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16: 270-275, 1995.
63. 2 receptor. Eur. J. Pharmacol. 225: 331-337; 1992.
64. 1A rdselective agonists. Eur. J. Pharmacol. 128: 295-298, 1986.
65. STERN, W. C., JOHNSON, A., BRONZINO, J. D. AND MORGANE, P. J.: Neuropharmacology of the afferent projections from the lateral hebenula and substantia nigra to the anterior raphe in the rat. Neuropharmacology 20: 979-989, 1981.
66. 2 receptor and α1-adrenoceptor antagonism. J. Clin. Psychopharmacol. 15: 11S-18S, 1995.
67. SWANSON, L. W.: The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9: 321-353, 1982.
68. TANDA, G., CARBONI, E., FRAU, R. AND DI CHIARA, G.: Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential? Psychopharmacol. 115: 285-288, 1994.
69. 3 receptors inhibit dopamine release. J. Pharmac. Exp. Ther. 270: 475-479, 1994.
70. VAN BOCKSTAELE, E. J., CESTARI, D. M. AND PICKEL, V. M.: Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: Potential sites for modulation of mesolimbic dopamine neurons. Brain Res. 647: 307-322, 1994.
71. VAN WIJNGAARDEN, I., TULP, M. TH. M. AND SOUDIJN, W.: The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188: 301-312, 1990.
72. VERTES, R. P.: A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313: 643-668, 1991.
73. WANG., R. Y.: Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res. Rev. 3: 123-140, 1981.
74. YOSHIMOTO, K. AND MCBRIDE, W. J.: Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res. 17: 401-407, 1992.
75. 1A agonist, 8-OH-DPAT, on midbrain DA neurons: A9/A10 differences. Soc. Neurosci. Abstr. 19: 1373, 1993.